Morgan Stanley stock
Price history
+15.12% over the period1 year: from $165.61 (November 13, 2025) to $190.65 (November 13, 2026), +15.12%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 13, 2026 | $190.65 |
| October 30, 2026 | $184.30 |
| September 30, 2026 | $188.08 |
| August 31, 2026 | $213.32 |
| July 31, 2026 | $210.42 |
| June 30, 2026 | $209.04 |
| May 29, 2026 | $208.00 |
| April 30, 2026 | $190.59 |
| March 31, 2026 | $164.57 |
| February 27, 2026 | $166.51 |
| January 30, 2026 | $182.80 |
| December 31, 2025 | $177.53 |
| November 28, 2025 | $169.66 |
| November 13, 2025 | $165.61 |
At a glance
The company
Financial holding company providing capital raising, financial advisory, wealth management, and investment management services globally
Latest results
Quarter to September 30, 2026 · EPS $3.03 (estimate $3.05)
Next event
TickerLandia's take on Morgan Stanley
- Pricier than usual relative to earnings: P/E on the latest fiscal year 19 vs a median of 14 over its last 10 fiscal years.
- Priced in line with similar companies: trailing 12-month P/E 15 vs 16 (−5%) in a group of 9.
- Strong point: Earnings stability (69/100 in its group). Weak point: Market momentum (37/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−17.91% from the 52-week high
Analysts · 26 analysts
Average target$211.50+10.94% vs. price
Buy 11 · Hold 14 · Sell 1 · Buy
TickerLandia Fingerprint: Morgan Stanley
Compared with similar companies: high earnings stability, high dividend, and weak momentum.
Financials and price compared with 47 companies in the capital markets industry, worldwide. Momentum and risk compared with 883 North American stocks.
Priceaverage57
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 15.1 68 Price/book 2.78 61 Forward P/E 13.9 61 Price/sales 3.73 40 Profitabilityaverage42
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 40.2% 38 Net margin 25.6% 36 ROE 18.0% 50 ROA 1.4% 24 Gross margin 87.3% 62 Earnings stabilityhigh69
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 3.6% 80 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 57 Growthaverage47
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +10.80% 51 Earnings growth (year over year) +8.20% 45 Average revenue growth (3 years) +9.60% 46 Financial strengthlow39
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength 4.90 24 Interest coverage 0.54 20 Current ratio 2.12 74 Dividendhigh64
How much it returns to shareholders, and for how long.
Metric Value Position in group Dividend yield 2.4% 45 Payout ratio 34.1% 52 Consecutive dividend years at least 34 years 94 Market momentumweak37
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −9.96% 22 Distance from 200-day average −1.99% 36 Relative strength (6 months) −3.17% 37 1-year return +15.12% 53 Riskaverage48
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 21.9% 32 Volatility (60 days) 28.8% 35 Beta (1 year) 1.45 77
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Morgan Stanley is pricier than in the past and in line with similar companies
On the latest fiscal year's earnings (2025), Morgan Stanley's P/E today is 18.7, above the median of its last 10 fiscal years (14.1; between 8.38 and 18.0 from 2016 to 2025). Morgan Stanley's P/E (trailing 12 months): 15.1, in line with the median of a group of 9 similar companies (15.9).
Compared with 9 similar companies
| Metric | Morgan Stanley | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 15.1 | Middle | |
| Forward P/E | 13.9 | Middle | |
| ROE | 18.0% | Middle | |
| Price/book | 2.78 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Morgan Stanley. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$20.19B
Latest quarter · Q3 2026
Net income
$4.91B
Latest quarter · Q3 2026
Quarterly net margin
24.3%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $297.99B
- P/E
- 15.1
- EPS
- $12.61
- Volume
- 4.44M
- Daily trading
- €1.07B
- Dividend yield
- 2.26%
- Last ex-dividend on October 30, 2026
How Morgan Stanley is changing
All resultsRevenue grew 7.9% a year on average over the last 5 years
Revenue has grown for 3 fiscal years in a row
Returns
Morgan Stanley returns with dividends
$1,000 invested in Morgan Stanley 5 years ago, on November 15, 2021, would be worth $2,227 today with dividends reinvested: +122.70% in total, +17.39% per year. On price alone it would be $1,903 (+90.25%).
| Period | Morgan Stanley | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +2.15% | −3.12% | $1,021 |
| 6 months | −1.64% | +1.58% | $984 |
| Year to date | +7.39% | +10.46% | $1,074 |
| 1 year | +17.72% | +12.23% | $1,177 |
| 3 years | +176.82% | +71.41% | $2,768 |
| 5 years | +122.70% | +61.48% | $2,227 |
| 10 years | +540.96% | +249.40% | $6,410 |
Over the last 6 months it has done better than 37% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Morgan Stanley: technical analysis
Morgan Stanley shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 16.6% below its all-time closing high ($228.55, July 15, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 53
- Between 30 and 70
- vs 200-session average
- −1.99%
Active signals
Death cross: the 50-session average has crossed below the 200-session average.
since November 10, 2026
Support and resistance
Price areas where Morgan Stanley has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$218.83+14.78%2 touches, last on September 8, 2026
- Resistance$207.24+8.70%5 touches, last on September 1, 2026
- Resistance$193.52+1.51%3 touches, last on October 13, 2026
- Last price$190.65
- Support$187.98−1.40%3 touches, last on May 12, 2026
- Support$183.12−3.95%3 touches, last on October 1, 2026
- Support$178.03−6.62%6 touches, last on November 5, 2026
Volatility and risk
Over the last year it has moved more than the S&P 500.
- Beta (1 year) vs S&P 500
- 1.45
- Volatility (60 sessions, annualised)
- 28.8%
- Largest fall in the last year
- −21.91%
Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Morgan Stanley: seasonality
Average monthly price change over 34 years
Over the last 34 years, the strongest month for Morgan Stanley has been January: +4.25% on average, positive in 22 years out of 33. The weakest has been September: −2.86% on average, positive in 17 years out of 34. November, the current month, has been positive in 20 years out of 33 (+2.67% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +4.25% | +2.97% | 22 of 33 |
| February | −1.27% | −0.85% | 13 of 33 |
| March | +0.75% | +1.23% | 20 of 34 |
| April | +2.42% | +2.41% | 21 of 34 |
| May | +0.81% | +1.19% | 18 of 34 |
| June | +0.72% | −0.08% | 17 of 34 |
| July | +2.20% | +1.46% | 23 of 34 |
| August | −1.03% | +0.74% | 18 of 34 |
| September | −2.86% | +0.30% | 17 of 34 |
| October | +4.13% | +3.91% | 25 of 34 |
| November | +2.67% | +2.98% | 20 of 33 |
| December | +2.90% | +2.15% | 23 of 33 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Morgan Stanley and its competitors
Morgan Stanley's largest business is Institutional Securities, which provides capital raising, financial advisory services such as underwriting and mergers and acquisitions advice, and sales, financing, prime brokerage and market-making in equity and fixed income products. The firm also runs Wealth Management, offering financial advisor-led brokerage, investment advisory, cash management, banking, securities-based lending and retirement plan services, and an Investment Management segment that serves pension and benefit plans, foundations, endowments, sovereign wealth funds, insurers and individuals.
- Headquarters
- New York, United States
- Employees
- 84,000
- Founded
- 1924
- Chief executive
- Edward Pick
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Morgan StanleyMS | $297.99B | 18.0% | 15.1 | −1.64% |
| Goldman Sachs GroupGS | $264.37B | 17.7% | 13.2 | −4.07% |
| Charles SchwabSCHW | $160.48B | 21.1% | 15.9 | +1.99% |
| Interactive Brokers GroupIBKR | $139.36B | 23.7% | 31.2 | −3.91% |
| Robinhood MarketsHOOD | $70.11B | 21.5% | 35.9 | +1.45% |
| Tradeweb MarketsTW | $27.63B | 14.5% | 28.1 | +20.82% |
Same industry or related industries, similar size. Compare Morgan Stanley with its competitors · Full profile
